Retrospective Quarterly Cohort Monitoring for patients with Visceral Leishmaniasis in the Indian subcontinent: outcomes of a pilot project-Reference-Cited by-同舟云学术

Retrospective Quarterly Cohort Monitoring for patients with Visceral Leishmaniasis in the Indian subcontinent: outcomes of a pilot project

Published:2013-03-07 Issue:6 Volume:18 Page:725-733
ISSN:1360-2276
Container-title:Tropical Medicine & International Health
language:en
Short-container-title:Trop Med Int Health

Author:

Ostyn Bart¹,Malaviya Paritosh²,Hasker Epco¹,Uranw Surendra³,Singh Rudra P.²,Rijal Suman³,Sundar Shyam²,Dujardin Jean-Claude¹,Boelaert Marleen¹

Affiliation:

1. Institute of Tropical Medicine; Antwerp; Belgium

2. Institute of Medical Sciences; Banaras Hindu University; Varanasi; India

3. B. P. Koirala Institute of Health Sciences; Ghopa; Dharan; Nepal

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Parasitology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tmi.12092/fullpdf

Reference27 articles.

1. Leishmaniasis worldwide and global estimates of its incidence;Alvar;PLoS ONE,2012

2. Elimination of leishmaniasis (kala-azar) from the Indian subcontinent is technically feasible and operationally achievable;Bhattacharya;Indian Journal of Medical Research,2006

3. The poorest of the poor: a poverty appraisal of households affected by visceral leishmaniasis in Bihar, India;Boelaert;Tropical Medicine and International Health,2009

4. Epidemiological analysis of tuberculosis treatment outcome as a tool for changing TB control policy in Israel;Chemtob;The Israel Medical Association Journal,2001

5. Drug resistance in leishmaniasis;Croft;Clinical Microbiology Reviews,2006

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antimony resistance mechanism in genetically different clinical isolates of Indian Kala-azar patients;Frontiers in Cellular and Infection Microbiology;2022-11-02

2. In vitro screening of known drugs identified by scaffold hopping techniques shows promising leishmanicidal activity for suramin and netilmicin;BMC Research Notes;2018-05-21

3. Epidemiology of Leishmaniasis in the Time of Drug Resistance (the Miltefosine Era);Drug Resistance in Leishmania Parasites;2018

4. Risk Factors associated with defaulting from visceral leishmaniasis treatment: analysis under routine programme conditions in Bihar, India;Tropical Medicine & International Health;2017-07-13

5. Visceral leishmaniasis diagnosis and reporting delays as an obstacle to timely response actions in Nepal and India;BMC Infectious Diseases;2015-02-06